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Recent advances of robotic surgery and single port 
laparoscopy in gynecologic oncology
Yong Wook Jung, Sang Wun Kim, Young Tae Kim
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea
Two innovative approaches in minimally invasive surgery that have been introduced recently are the da Vinci robotic 
platform and single port laparoscopic surgery (SPLS). Robotic surgery has many advantages such as 3-dimensional 
view, the wrist like motion of the robotic arm and ergonomically comfortable position for the surgeon. Numerous 
literatures have demonstrated the feasibility of robotic surgery in gynecologic oncology. However, further research 
should be performed to demonstrate the superiority of robotic surgery compared to conventional laparoscopy. 
Additionally, cost reduction of robotic surgery is needed to adopt robotic surgery into gynecologic oncology worldwide. 
SPLS has several possible benefits including reduced operative complications, reduced postoperative pain, and better 
cosmetic results compared to conventional laparoscopy. Although several authors have indicated that SPLS is a feasible 
approach for gynecologic surgery, there have been few reports demonstrating the potential advantages over conventional 
laparoscopy. Moreover, technical difficulties of SPLS still exist. Therefore, the advantages of a single port approach 
compared to conventional laparoscope should be evaluated with comparative study, and further technologic 
development for SPLS is also needed. These two progressive technologies take the lead in the development of MIS and 
further studies should be performed to evaluate the benefits of robot surgery and SPLS.
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INTRODUCTION
Operative laparoscopy developed earlier on in the field of gy-
necology and the appearance of minimally invasive surgery 
(MIS) led to advances in general surgery as well. Operative 
laparoscopy was initiated in the 1970s, and tubal ligations for 
contraception were conducted with laparoscopy in women by 
the mid 1970s.1 Since laser and electric energy technology was 
integrated into laparoscopic surgery in the early 1980s, oper-
ative laparoscopy extended to complicated gynecologic proce-
dures including hysterectomy, adnexal surgery and uterine 
myomectomy. Now, laparoscopic surgery has become an es-
sential part of surgical treatment for gynecologic diseases, in-
cluding gynecologic cancers. Compared with laparotomy, lap-
aroscopic approach offers several advantages, such as faster 
return to normal activity, better cosmetic results, shorter 
length of hospital stay, lower cost, and reduced pain. 
The technology and techniques related to laparoscopic sur-
gery are still evolving to the direction of easier and less in-
vasive laparoscopic surgery. Despite several advantages of 
laparoscopic surgery, the weakness of conventional laparo-
scopy including an unstable camera platform, the limited mo-
bility of straight laparoscopic instruments, two-dimensional 
imaging, a poor ergonomic position for the surgeon, and a 
steep learning curve still remains. As easier laparoscopic ap-
proach, the robotic platforms that address many of the current 
limitations of conventional laparoscopy were developed and 
integrated into laparoscopic surgery. Recently, another in-
novative technique, single port laparoscopic surgery (SPLS), 
was also introduced in the field of MIS. Both robotic platform 
and SPLS are emerging concepts in MIS. The purpose of this 
study is to provide an overview of these cutting edge tech-
nologies in gynecologic oncology. 
HISTORY OF ROBOTIC SURGERY
The term “robot” was first introduced to the public in 1921 
when the Czech writer Karel Capek described the notion in his 
play Rossum’s Universal Robots.2 The term “robot” origi-
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nated from “robota”, which means literally “work” or “forced 
labor” in the Czech language. For decades, robots have ach-
ieved substantial development from simple machines per-
forming repetitive tasks to a highly sophisticated machine, ca-
pable of performing specific tasks requiring precision. 
In the surgical field, automated endoscopic system for opti-
mal positioning (AESOP) was launched as the first laparo-
scopic camera holder by Computer Motion Inc. (Computer 
Motion, Inc., Santa Barbara, CA, USA).3 Although AESOP has 
been used in over 10,000 laparoscopic surgeries, it was only 
designed to offer greater vision control to the surgeon and to 
eliminate the need for an assistant who manipulated the 
endoscope.
In 1992, ROBODOC (Integrated Surgical Supplies, Inc., 
Sacramento, CA, USA), the first commercially available ro-
botic system, was introduced in orthopedic surgery, and nu-
merous cases of total hip replacement surgery were success-
fully performed with this robot system.4 The ROBODOC uti-
lized a robotic arm designed to make precise cuts in the femur 
bone for the insertion of surgical implants, based on the 
three-dimensional computerized tomography image. However, 
it is difficult to call these surgeries assisted by ROBODOC and 
AESOP as true robotic surgery because of the limited role in 
performing surgical procedures with these robotic systems.
In 1998, Computer Motion which already had manufactured 
the AESOP developed the ZEUS surgical robot with a 2-di-
mensional imaging system similar to that of standard 
laparoscopy. Using the ZEUS robotic system, the first tele-ro-
botic surgery was conducted by a surgeon in New York on a 
patient in France and was reported by Marescaux et al.5 On the 
other hand, the da Vinci surgical system was introduced by 
Intuitive Surgical, Inc. (Intuitive Surgical, Mountain View, 
CA, USA), and a more advanced da Vinci surgical system with 
four robotic arms obtained US Food and Drug Administration 
(FDA) approval in 2001. It is now being used in various surgi-
cal procedures throughout the world. The first tele-surgery 
using the da Vinci robotic system was conducted between the 
University of Cincinnati and Intuitive Surgical in California in 
2006.6 The ongoing competition between the ZEUS and the 
da Vinci surgical systems ended when Computer Motion Inc. 
was merged into Intuitive Surgical Inc. in 2003. In Korea, the 
Korean FDA approved the da Vinci system in July 13th, 2005 
and the first robot assisted laparoscopic hysterectomy was 
conducted by Kim et al.7 on January 31st in 2006. The da Vinci 
system is currently being used at the departments of gynecol-
ogy, general surgery, urology and thoracic surgery in Korea. 
For 3 years, more than 2,000 cases of robotic surgeries in vari-
ous fields have been performed at our institution. 
ROBOT ASSISTED LAPAROSCOPIC SURGERY USING 
THE DA VINCI SURGICAL SYSTEM
The da Vinci robotic system, which is the only FDA approved 
and commercially available robot in gynecology, consists of 
three main components: the robotic cart, the vision cart, and 
the operating console (Fig. 1). Four robotic arms are mounted 
on the robotic cart, which can be placed freely next to the 
patient. The robotic cart docked to the laparoscopic trocars on 
the patient’s abdomen is connected to the operating console 
through a cable. The da Vinci surgical system is equipped with 
a 3-dimensional vision system, in which double endoscopes 
generate two images resulting in the perception of a 3D image. 
In addition, robotic arms with surgical instruments have three 
or four joints, which reproduce the range of motion and dex-
terity of the surgeon’s hand. The surgeon sits at the surgical 
console and performs the surgery by manipulating the con-
troller in it. The movement is translated from the surgeon's 
fingers to the tip of the surgical instruments. During this proc-
ess, the physiologic tremor is eliminated by the robotic 
system. These instruments including the 3-D vision system 
and endowrist allow the surgeon to conduct more precise sur-
gical procedures during surgery. 
ROBOT ASSISTED LAPAROSCOPIC SURGERY IN 
GYNECOLOGIC CANCER
Cervical cancer is the leading cause of cancer-related death in 
women worldwide and accounts for 5.7% of all new cancer 
cases in Korean women in 2005, with approximately 3,737 in-
vasive cervical cancer cases being diagnosed.8 Endometrial 
cancer is also one of the most common malignancies of the fe-
male genital tract in developed countries.9 Surgery for these 
gynecologic cancers is considered to be one of the major man-
agement modalities for treating cancer, determining disease 
stage of patients, and obtaining the information for adjuvant 
treatment. However, laparotomic approaches in all patients 
with cervical or endometrial cancer have increased operative 
and post-operative morbidity. To reduce the surgical morbid-
ity, robot assisted laparoscopic surgery was introduced as an 
alternative surgical method for laparotomic surgery in gyne-
cologic cancers. Therefore, examining the surgico-feasibility 
of robotic approach in these cancers is an essential step for 
further discussion about the feasibility in all aspects.  
In cervical cancer, Kim et al.10 offered the evidence for the 
feasibility of performing robot assisted laparoscopic radical 
hysterectomy in their case series report. Since the study by 
Kim and colleagues was published, several authors elaborated 
on the surgical outcomes, which were obtained with robotic 
procedures compared to those of conventional laparoscopic or 
laparotomic surgeries.11-16 Magrina et al.17 reported that ro-
botic and conventional laparoscopic surgeries are preferable 
to laparotomy for patients requiring radical hysterectomy in 
terms of blood loss and length of hospital stay. Boggess et al.16 
conducted a case-control study of robot assisted laparoscopic 
radical hysterectomy compared with laparotomic approach, 
and this study showed that robot assisted laparoscopic radical 
hysterectomy is superior to open radical hysterectomy with 
regard to blood loss, operative time, hospital stay, and lymph 
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Fig. 1. The da Vinci surgical system. (A) Surgical console, (B) Robotic cart, (C) Vision cart, (D) Three dimensional vision system with endo-
scope, (E) Endowrist.
Table 1. Literatures of robot assisted laparoscopic radical hysterectomy in cervical cancer
Authors Year Cases
Median operative time,
 min (range)
Median estimated 
blood loss, ml (range)
Median number of resected 
pelvic lymph nodes (range)
Complication 
rate, %
Kim et al.10
Magrina et al.14
Boggess et al.16
Fanning et al.15
Estape et al.13
Persson et al.11
Lowe et al.12
Maggioni et al.18
2008
2008
2008
2008
2009
2009
2009
2009
10
27
51
20
32
80
42
40
207 (120-240)
185 (119-281)
210.9±45.5*
6.5 hr (3.5-8.5)
2.4±0.8* hr
262 (132-475)
215 (120-606)
272.3±42.3*
355 (200-450)
100 (50-600)
96.5±85.8*
300 (100-475)
130.0±119.4*
150 (25-1300)
50 (25-150)
78±94.8*
28 (12-52)
26 (10-36)
33.8±14.2*
18 (15-35)
32.4±10.0*
26 (15-55)
25 (12-60)
20.4±6.9*
10.0
25.9
7.8
10.0
18.8
41.0
16.8
32.5
*Mean±standard deviation.
node retrieval. Lowe et al.12 also reported the experience of 
multi-institution consortium which consists of five gyneco-
logic oncologists in distinct geographical regions of the 
United States for radical hysterectomy using the da Vinci ro-
botic platform. Through the analysis of 42 patients who un-
derwent a type II or III robotic radical hysterectomy, the au-
thors concluded that robot assisted laparoscopic type II/III 
radical hysterectomy is associated with a shortened hospital 
stay, few operative complications, acceptable lymph node 
yields, and acceptable operative times. Table 1 summarizes 
the current literature presenting surgical outcomes of robot 
assisted radical hysterectomy.
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Table 2. Literatures of robot assisted laparoscopic staging surgery in endometrial cancer
Authors Year Cases
Median operative 
time, min (range)
Median estimated 
blood loss, 
ml (range)
Median number of 
resected pelvic lymph 
nodes (range)
Median number of resected
para-aortic lymph 
nodes (range)
Complication
rate, %
Bell et al.18
Boggess et al.19
DeNardis et al.20
Seamon et al.24
Veljovich et al.25
Peiretti et al.22
Lowe et al.21
2008
2008
2008
2008
2008
2009
2009
40
103
56
105
25
80
405
184.0±41.3†
191.2±36.0†
177±55†
242±50†
283 (171-443)
170 (75-390)
170.5±68.9†
 253±427.7†
74.5±106.2†
105±77†
99±83†
66.6 (10-300)
 50 (5-150)
87.5±97.4†
17.1±7.1*†
20.5±13.6†
13.3±8.6†
12.7±8.4†
17.5 (2-32)*
15.5 (3-33)*
 21 (5-40) 
12.0±9.0†
6.5±4.4†
2.8±3.1†
9 (2-21)
7.5
5.8
10.7
12.9
20
23.8
18.1
* Total number of resected lymph nodes, †Mean±standard deviation.
As many researchers demonstrated the feasibility of robotic 
radical hysterectomy in cervical cancer, several authors 
showed that the robot assisted staging surgery in endometrial 
cancer is comparable to conventional laparoscopic and lapa-
rotomic approach in terms of surgical outcomes.19-26 In addi-
tion, length of hospital stay, blood loss and peri-operative 
complication rates are significantly lower in patients who re-
ceived robotic surgery than those who underwent lapa-
rotomic staging surgery. Comparing with laparoscopic stag-
ing, the advantages of robot assisted laparoscopic staging sur-
gery are somewhat distinct in obese patients with regard to 
surgical outcomes.27,28 Gehrig et al.29 conducted a com-
parative study to examine which is the optimal minimally in-
vasive surgical approach between conventional laparoscopy 
and robot for obese patients with endometrial cancer. The au-
thors reported that robotic surgery was associated with short-
er operative time, less blood loss, increased number of re-
sected lymph nodes and shorter hospital stay compared to tra-
ditional laparoscopy. Seamon et al.27 also performed a com-
parative study in order to compare outcomes between robotic 
and laparoscopic staging for endometrial cancer. The authors 
showed that robotic staging surgery for endometrial carcino-
ma in heavier women resulted in shorter operation times, 
shorter hospital stay, lower transfusion rate, and less frequent 
conversion to laparotomy when compared to laparoscopic 
staging. Table 2 presents publications of robotic surgery for 
endometrial cancer staging.
Numerous investigators demonstrated that laparoscopic ap-
proach in performing radical hysterectomy or endometrial 
cancer staging operation was not only feasible, but also 
achievable.29-33 However, a recent survey investigating the use 
of MIS by the Society of Gynecologic Oncology (SGO) mem-
bers showed that only 26% of SGO members considered lapa-
roscopic radical hysterectomy as an appropriate approach to 
the management of cervical cancer.34 The Korean Gynecologic 
Oncology Group (KGOG) Survey also revealed that only 49% 
of KGOG members used laparoscopy for endometrial cancer 
staging surgery.35 The potential obstacles to the widespread 
acceptance of minimally invasive approach in gynecologic 
cancer are the technical difficulties of conventional laparo-
scopic surgery. Seamon et al.36 demonstrated that the learning 
curve for endometrial cancer staging with the robot platform 
required only 20 cases to reach the state of efficiency. The 
learning curve of achievement in endometrial cancer staging 
surgery using the da Vinci surgical system was shorter than 
that of conventional laparoscopic surgery. Although there was 
lack of data showing learning curve of robotic surgery in radi-
cal hysterectomy, all investigators who investigated the feasi-
bility of robotic radical hysterectomy compared to laparotomy 
reported acceptable surgical outcomes in their initial experi-
ences with the robot system.  
Robotic surgery has many advantages, such as 3-dimen-
sional view, the wrist like motion of the robotic arm and ergo-
nomically comfortable position for the surgeon. These advan-
tages offer significant technical ease in performing compli-
cated surgical procedures, including suturing and tying of 
knots by the surgeon, providing a familiar environment sim-
ilar to that of the laparotomic approach.
Although there are several advantages of robotic surgery, it 
still has disadvantages. The principal weak point is the high 
cost of robotic surgery, which prevents robotic surgery from 
spreading worldwide. The cost to install the da Vinci robotic 
platform in an institution ranges from $1,000,000 to 
$1,500,000 and a 10% annual maintenance fee is needed 
separately.37 The expense for robotic instruments, which can 
be used only ten times, adds significant charge to the total 
cost. According to the report by Bell et al.19 total average cost, 
including hospital charges, for endometrial cancer staging 
surgery with laparotomy, conventional laparoscopy and robot 
assisted laparoscopy were approximately $13,000, $7,600 
and $8,200, respectively. Although there was no statistically 
significant difference in cost between laparoscopy and robotic 
surgery in the United States, the cost for surgical approach dif-
fers according to the medical insurance systems and cultures 
of each country. Persson et al.11 in Sweden raised a question 
about the cost efficiency of robotic radical hysterectomy com-
pared with laparoscopy or laparotomy. In Korea, the govern-
ment-driven medical insurance system is under strict control, 
such that the cost of medical treatment for patients who un-
derwent robotic radical hysterectomy cannot obtain medical 
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benefits from the government medical insurance system, and 
have to pay the high cost of surgery. A cost effectiveness analy-
sis for hysterectomy using three surgical methods by Chung et 
al.38 revealed that laparoscopic approach is the most cost sav-
ing approach in Korea. 
Other disadvantages included absence of tactile feedback of 
robotic arms, requirement of larger ports for robotic surgery 
compared to conventional laparoscopic staging surgery. 
Placement of a large sized port, more than 8-mm in diameter 
for robotic surgery, is larger than that of laparoscopic surgery, 
and causes aggravated postoperative pain and produce poor 
cosmetic results. Additionally, trocar site hernia through the 
8-mm port may occur more frequently than the 5-mm port. 
Though trocar site herniation is a rare complication in gyneco-
logic laparoscopic surgery, it develops more frequently when 
large ports (10mm in diameter or larger) are used, and rare in 
less than 10-mm ports, ranging from 0 to 0.09%.39 In fact, 
Seamon, et al. reported a case of small bowel evisceration 
through an 8-mm robotic port site after endometrial cancer 
staging surgery.40 Therefore, to achieve lower complication 
rates, port size must be reduced. 
So far, most of the studies demonstrating the feasibility of 
robotic approach in performing radical hysterectomy or endo-
metrial cancer staging surgery were retrospective in nature, or 
conducted in a single institution. In addition, several re-
searchers demonstrated that the open approach was still su-
perior to the robotic approach in terms of the number of re-
sected lymph nodes.18 Literatures concerning long term sur-
vival in patients with these gynecologic cancers who under-
went robot assisted laparoscopic surgery are limited. There-
fore, the feasibility of robotic surgery compared to other ap-
proaches should be supported by prospectively designed mul-
ti-center studies, which are sufficient to evaluate the role of 
the robotic platform in conducting radical hysterectomy or 
endometrial cancer staging surgery. The research regarding 
long term survival in cervical or endometrial cancer patients, 
who underwent robot assisted laparoscopic surgery, should 
also be performed.
HISTORY OF SINGLE PORT LAPAROSCOPIC SURGERY 
IN GYNECOLOGY
Innovation in technology and techniques continues more 
minimal approach to be attained than traditional laparoscopic 
surgery; SPLS is one of those innovative techniques. As sur-
geons in gynecology were pioneers in laparoscopic surgery, 
the frontiers of SPLS were in gynecology. In fact, the single 
port approach had already been widely used in gynecology. 
Wheeless41 performed the first single incision tubal ligation in 
1969. In the 1970s, several gynecologists conducted laparo-
scopic tubal ligations with Yoon’s rings through a single um-
bilical incision.42 After that time, total hysterectomy with bi-
lateral salpingo-oophorectomy using single puncture techni-
que was performed by Pelosi43 in 1991. However, hyster-
ectomy using SPLS did not gain widespread use due to techni-
cal difficulties. In 2005, Ghezzi et al.44 presented a novel tech-
nique for the treatment of tubal pregnancy; one trocar 
salpingectomy. The authors made only one incision below the 
umbilicus for a 10 mm operative laparoscope and inserted a 
90 cm suture on a straight hand needle percutaneously to ma-
nipulate the distal tube. Ten cases of tubal pregnancies were 
successfully treated with this technique. However, technical 
challenges for more complicated gynecologic procedures still 
exist in SPLS, and originates from breakdown in triangu-
lation, which is necessary for maintaining appropriate oper-
ative field during laparoscopic surgery. Technological in-
novations in the field of laparoscopic surgery have been re-
markable, and complicated procedures, such as cholecystec-
tomy and appendectomy using single port laparoscopy in the 
field of general surgery. At the same time, several gynecolo-
gists also demonstrated the feasibility of SPLS for hyster-
ectomy and adnexal surgery. 
FEASIBILITY OF SPLS IN GYNECOLOGY
The principle concept of SPLS is to place all of the laparo-
scopic working ports through the same incision. However, 
this principle results in hand collisions out of the abdomen 
and clashing of instruments within the abdomen. Now, vari-
ous devices designed to overcome the technical challenges for 
SPLS have been developed and introduced in gynecology.45 
Those devices include laparoscopic ports designed to apply 
multiple instruments through a single incision, flexible/long 
endoscopes and articulating/variable length instruments. In 
addition, the da Vinci robotic platforms with articulating in-
struments can be integrated into SPLS for hysterectomy or 
salpingo-oophorectomy. Fig. 2 represents the devices which 
are used at our institution in performing SPLS for hyster-
ectomy and adnexal surgery.
Recently, Korean gynecologic oncologists reported their ini-
tial experiences of SPLS in gynecology. Lim et al.46 demon-
strated that SPLS is a promising approach for adnexal tumor. 
The median time of operation was 73 minutes (range, 25 to 
110 minutes). Blood loss was 10 ml (range 5 to 100 ml). Lee 
et al.47 also successfully performed laparoscopic assisted vagi-
nal hysterectomy (LAVH) in 21 patients with uterine fibroids 
using a single port access. The median operative time and the 
median blood loss were 119 minutes and 400 ml, respectively. 
These authors created a single port using a wound retractor, 
a surgical glove, and three conventional laparoscopic trocars. 
We have also submitted and are revising our initial experi-
ences of total laparoscopic hysterectomy with SPLS. In a 6 
month period, 29 patients with gynecologic disease under-
went SPLS at our institution. The median operative time was 
100 minutes and the median blood loss was 100 ml.  
Fader and Escobar48 also conducted 13 cases of single port 
gynecologic surgery including 1 endometrial cancer staging, 1 
ovarian cancer staging, 1 retroperitoneal pelvic lymph node 
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Fig. 2. Single port laparoscopic surgery. (A) A single 3-channel port using a wound retractor, a surgical glove, and three conventional laparo-
scopic trocars, (B) Postoperative wound, (C) Long endoscope.
Table 3. Literatures of single port laparoscopic approach in gynecology
Author Year Cases Procedures
Median operative
time, min (range)
Median estimated 
blood loss, ml (range)
Conversion to other
method, no. (%)
Complication 
rate, %
Lim et al.46
Lee et al.47
Fader et al.48
2008
2009
2009
12
24
13
Adnexectomy
Vaginal hysterectomy
Adnexectomy, hysterectomy,
  pelvic lymphadenectomy
73 (25-110)
119 (90-255)
65 (35-178)
10 (5-100)
400 (100-1000)
N/A
0
3 (12.5)
0
0
0
0
dissection, 2 hysterectomy with bilateral salpingo-oophorec-
tomy, 7 bilateral salpingo-oophorectomy and 1 ovarian cy-
stectomy. The authors used the da Vinci robot system in 4 
cases. Table 3 represents the literature demonstrating the fea-
sibility of SPLS in gynecology. 
There are possible advantages of SPLS in gynecology. First, 
operative complications related trocar insertion such as epi-
gastric vessel injury, visceral organ herniation, wound infection, 
and visceral organ damage might be reduced by eliminating 
the need of ancillary ports. Second, postoperative pain, which 
results from skin incision and penetrating muscle and fascia 
with the trocar, might be reduced. Third, a better cosmetic re-
sult may also be obtained. Fourth, in cases of adnexectomy, re-
sected specimens can be easily extracted through the larger 
umbilical incision of the SPLS than that of conventional lapa-
roscopy. However, there is no literature which examines the 
potential benefits of SPLS in gynecology compared to the con-
ventional laparoscopic approach. Therefore, the advantages of 
a single port approach compared to conventional laparoscopy 
should be evaluated in a randomized prospective study. 
Despite novel devices for SPLS, clashing of laparoscopic in-
struments and limited vision of in-line view are potential dis-
advantages of SPLS. These weaknesses which cause longer op-
erative times and longer learning curves might be major ob-
stacles for the popularity of SPLS. Therefore, increased efforts 
to develop surgical instruments which can overcome these 
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technical problems should continue. Other disadvantages as-
sociated with SPLS are the need for special instruments, the 
increased risk of umbilical hernia due to larger umbilical in-
cision, and the difficulty in training of residents/fellows for 
MIS.
SPLS is considered a feasible approach for hysterectomy and 
adnexectomy in gynecology. In the field of gynecologic oncol-
ogy, SPLS may be applied to adnexal surgery in patients with 
adnexal tumors, prophylactic oophorectomy in patients with 
high risk of developing ovarian cancer, and hysterectomy in 
patients with preinvasive cervical neoplasia or microinvasive 
cervical cancer. If technical advances are achieved in laparo-
scopic instruments, including the robotic system, more com-
plicated procedures in gynecologic oncology, such as radical 
hysterectomy and comprehensive endometrial cancer staging 
surgery might be conducted with SPLS in the near future.  
CONCLUSION
The numerous benefits of MIS are better cosmetic results, 
reduced operative morbidity, reduced postoperative pain, and 
shorter length of hospital stay compared with laparotomic 
surgery. MIS has taken the place of laparotomic approach and 
has become an imperative part of surgical approach in gyneco-
logic oncology. However, technical difficulties have prevented 
the widespread adoption of MIS in gynecologic oncology. 
Over the last three decades, laparoscopic technologies have 
evolved remarkably, and robotic surgery using the da Vinci 
system has been introduced. Although it is not evident that 
robotic surgery is superior to conventional laparoscopic sur-
gery in terms of surgical outcomes, current evidence demon-
strates the positive feasibility of robot assisted laparoscopic 
surgery in gynecologic oncology. Robotic surgery is consid-
ered a stepping-stone to jump over the technical barriers of 
MIS, and contributes to widespread adoption of MIS. However, 
the economic feasibility of robotic surgery still remains as an-
other obstacle to be solved. It is expected with further devel-
opment of robotic technology and the emergence of a com-
petitor to the da Vinci robotic platform, the issue of high cost 
will be resolved. 
On the other hand, SPLS is a cutting edge technology requir-
ing high degree of technique. Despite its demonstrated feasi-
bility in gynecology and newly introduced devices, there are 
several matters that need to be solved, such as demonstrating 
superiority of the SPLS compared with conventional laparo-
scopic approach, and relieving technical difficulties. There-
fore, further research should focus on the evaluation of the po-
tential benefits of the SPLS and prompt technological pro-
gress. In the 21st century, these two innovative approaches; 
robot and SPLS takes the lead in the development of MIS.
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